AU2001280974A1 - Identification of new therapeutic targets for modulating bile acid synthesis - Google Patents

Identification of new therapeutic targets for modulating bile acid synthesis

Info

Publication number
AU2001280974A1
AU2001280974A1 AU2001280974A AU8097401A AU2001280974A1 AU 2001280974 A1 AU2001280974 A1 AU 2001280974A1 AU 2001280974 A AU2001280974 A AU 2001280974A AU 8097401 A AU8097401 A AU 8097401A AU 2001280974 A1 AU2001280974 A1 AU 2001280974A1
Authority
AU
Australia
Prior art keywords
identification
bile acid
acid synthesis
new therapeutic
therapeutic targets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280974A
Inventor
Bryan James Goodwin
Stacey Ann Jones
Steven Anthony Kliewer
Patrick Reed Maloney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001280974A1 publication Critical patent/AU2001280974A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
AU2001280974A 2000-07-31 2001-07-30 Identification of new therapeutic targets for modulating bile acid synthesis Abandoned AU2001280974A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22170800P 2000-07-31 2000-07-31
US60/221,708 2000-07-31
PCT/US2001/024203 WO2002010769A2 (en) 2000-07-31 2001-07-30 Identification of new therapeutic targets for modulating bile acid synthesis

Publications (1)

Publication Number Publication Date
AU2001280974A1 true AU2001280974A1 (en) 2002-02-13

Family

ID=22828997

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280974A Abandoned AU2001280974A1 (en) 2000-07-31 2001-07-30 Identification of new therapeutic targets for modulating bile acid synthesis

Country Status (2)

Country Link
AU (1) AU2001280974A1 (en)
WO (1) WO2002010769A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04012560A (en) * 2002-06-13 2005-10-19 Wyeth Corp Inhibitors of inflammatory gene activity and cholesterol biosynthesis.
JP2005532052A (en) * 2002-07-01 2005-10-27 ファルマシア・コーポレーション Antisense regulation of LRH1 expression
WO2005114204A2 (en) * 2004-05-13 2005-12-01 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 0, group b, member 2 (nr0b2)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2051600A (en) * 1998-12-10 2000-06-26 Board Of Regents, The University Of Texas System Compositions and methods of modulating cholesterol metabolism

Also Published As

Publication number Publication date
WO2002010769A3 (en) 2002-11-28
WO2002010769A2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2754501A (en) Treatment of acne using lipoic acid
AU1967901A (en) Detachable coil for aneurysm therapy
AU6008499A (en) Controlled drug release system of retinoic acid
AU2002236559A1 (en) Minimally invasive system for assessment of organ function
AU7870900A (en) Treatment of scar tissue using lipoic acid
AU3213200A (en) Inhibitors of intestinal apical membrane na/phosphate co-transportation
AU1283200A (en) Propanoic acid derivatives as integrin inhibitors
EP1108008A4 (en) Novel ubiquitin ligases as therapeutic targets
AU2002235520A1 (en) Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
AU2001288360A1 (en) Genomics-assisted rapid identification of targets
AU2199401A (en) Propanoic acid derivatives as integrin inhibitors
AU2001286163A1 (en) An improved process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
AU2001280974A1 (en) Identification of new therapeutic targets for modulating bile acid synthesis
AU7445100A (en) Sebum production inhibitors
AUPQ365299A0 (en) Anthranilic acid derivatives
AU2252101A (en) New synthesis of SPLA2 inhibitors
AU2001292301A1 (en) Novel drugs for liver diseases
IL149364A0 (en) Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
AU2002322551A1 (en) Antisense modulation of rip2 expression
AU6497300A (en) Use of salicylic acid for regulating hyperpigmented spots
AU2001279649A1 (en) Use of organophosphorous hydroxamic acid derivatives for producing medicaments
AU2001288238A1 (en) Methods of modulating activity of dxr
AU8178901A (en) Button-shaped plate for reconstructive surgery of tendon-bone lesions
AU2001273189A1 (en) Process for the preparation of derivatives of 4-amino-3-hydroxypyrrole-2-carboxylic acid
AU2001289723A1 (en) Novel use of difluoromalonic acid esters